These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

443 related items for PubMed ID: 15047939

  • 1. Administration of low-dose LH induces ovulation and prevents vascular hyperpermeability and vascular endothelial growth factor expression in superovulated rats.
    Gómez R, Lima I, Simón C, Pellicer A.
    Reproduction; 2004 Apr; 127(4):483-9. PubMed ID: 15047939
    [Abstract] [Full Text] [Related]

  • 2. Administration of moderate and high doses of gonadotropins to female rats increases ovarian vascular endothelial growth factor (VEGF) and VEGF receptor-2 expression that is associated to vascular hyperpermeability.
    Gómez R, Simón C, Remohí J, Pellicer A.
    Biol Reprod; 2003 Jun; 68(6):2164-71. PubMed ID: 12606463
    [Abstract] [Full Text] [Related]

  • 3. Preimplantation embryo development and serum steroid levels in immature rats induced to ovulate or superovulate with pregnant mares' serum gonadotropin injection or follicle-stimulating hormone infusions.
    Leveille MC, Armstrong DT.
    Gamete Res; 1989 May; 23(1):127-38. PubMed ID: 2501205
    [Abstract] [Full Text] [Related]

  • 4. Prevention of the onset of ovarian hyperstimulation syndrome (OHSS) in the rat after ovulation induction with a low molecular weight agonist of the LH receptor compared with hCG and rec-LH.
    van de Lagemaat R, Raafs BC, van Koppen C, Timmers CM, Mulders SM, Hanssen RG.
    Endocrinology; 2011 Nov; 152(11):4350-7. PubMed ID: 21896671
    [Abstract] [Full Text] [Related]

  • 5. Effects of gonadotropin-releasing hormone antagonists on the expression of vascular endothelial growth factor and its receptors in a rat model of ovarian hyperstimulation syndrome.
    Tong XM, Zhang SY, Song T, Xu WH, Lin XN, Shu J, Liu L.
    Chin Med J (Engl); 2008 Dec 05; 121(23):2434-9. PubMed ID: 19102964
    [Abstract] [Full Text] [Related]

  • 6. Effects of hyperstimulation with gonadotrophins and age of females on oocytes and their metaphase II status in rats.
    Tain CF, Goh VH, Ng SC.
    Mol Reprod Dev; 2000 Jan 05; 55(1):104-8. PubMed ID: 10602280
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of low dose hCG for luteal support after triggering ovulation with a GnRH agonist in cases of polyfollicular development.
    Krause BT, Ohlinger R.
    Eur J Obstet Gynecol Reprod Biol; 2006 May 01; 126(1):87-92. PubMed ID: 16377065
    [Abstract] [Full Text] [Related]

  • 8. Strain variation of immature female rats in response to various superovulatory hormone preparations and routes of administration.
    Corbin TJ, McCabe JG.
    Contemp Top Lab Anim Sci; 2002 Mar 01; 41(2):18-23. PubMed ID: 11958598
    [Abstract] [Full Text] [Related]

  • 9. Physiology and pathology of ovarian hyperstimulation syndrome.
    Gómez R, Soares SR, Busso C, Garcia-Velasco JA, Simón C, Pellicer A.
    Semin Reprod Med; 2010 Nov 01; 28(6):448-57. PubMed ID: 21082502
    [Abstract] [Full Text] [Related]

  • 10. Immunohistochemical detection of transforming growth factor-alpha, epidermal growth factor, and vascular endothelial growth factor expression in hyperstimulated rat ovary.
    Ozcakir HT, Giray SG, Ozbilgin MK, Uyar Y, Lacin S, Caglar H.
    Acta Obstet Gynecol Scand; 2005 Sep 01; 84(9):887-93. PubMed ID: 16097982
    [Abstract] [Full Text] [Related]

  • 11. Changes of mRNA expression of vascular endothelial growth factor, angiopoietins and their receptors during the periovulatory period in eCG/hCG-treated immature female rats.
    Miyabayashi K, Shimizu T, Kawauchi C, Sasada H, Sato E.
    J Exp Zool A Comp Exp Biol; 2005 Jul 01; 303(7):590-7. PubMed ID: 15945074
    [Abstract] [Full Text] [Related]

  • 12. Gonadotropin-releasing hormone agonist administration reduced vascular endothelial growth factor (VEGF), VEGF receptors, and vascular permeability of the ovaries of hyperstimulated rats.
    Kitajima Y, Endo T, Manase K, Nishikawa A, Shibuya M, Kudo R.
    Fertil Steril; 2004 Mar 01; 81 Suppl 1():842-9. PubMed ID: 15019818
    [Abstract] [Full Text] [Related]

  • 13. [Therapeutic induction of ovulation: towards the replacement of hCG with LH].
    Emperaire JC.
    Contracept Fertil Sex; 1994 Mar 01; 22(7-8):459-67. PubMed ID: 7920947
    [Abstract] [Full Text] [Related]

  • 14. Recombinant follicle-stimulating hormone induces ovulation and tissue plasminogen activator expression in hypophysectomized rats.
    Galway AB, Lapolt PS, Tsafriri A, Dargan CM, Boime I, Hsueh AJ.
    Endocrinology; 1990 Dec 01; 127(6):3023-8. PubMed ID: 2123446
    [Abstract] [Full Text] [Related]

  • 15. [The Predictive Role of Vascular Endothelial Growth Factor and Estradiol in Infertile Patients with Ovarian Hyperstimulation Syndrome].
    Wang Q, Yang G, Yang C, Zhan B, Yang R.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2003 Jul 01; 34(3):565-7. PubMed ID: 12910723
    [Abstract] [Full Text] [Related]

  • 16. Clinical effects of ovulation induction with recombinant follicle-stimulating hormone supplemented with recombinant luteinizing hormone or low-dose recombinant human chorionic gonadotropin in the midfollicular phase in microdose cycles in poor responders.
    Berkkanoglu M, Isikoglu M, Aydin D, Ozgur K.
    Fertil Steril; 2007 Sep 01; 88(3):665-9. PubMed ID: 17292895
    [Abstract] [Full Text] [Related]

  • 17. Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome.
    Scotti L, Irusta G, Abramovich D, Tesone M, Parborell F.
    Mol Cell Endocrinol; 2011 Mar 30; 335(2):116-25. PubMed ID: 21238536
    [Abstract] [Full Text] [Related]

  • 18. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B, Aboulghar M, Smitz J, Ron-El R.
    Hum Reprod Update; 1997 Mar 30; 3(3):255-66. PubMed ID: 9322101
    [Abstract] [Full Text] [Related]

  • 19. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome.
    Soares SR, Gómez R, Simón C, García-Velasco JA, Pellicer A.
    Hum Reprod Update; 2008 Mar 30; 14(4):321-33. PubMed ID: 18385260
    [Abstract] [Full Text] [Related]

  • 20. Vascular endothelial growth factor receptor-2 activation induces vascular permeability in hyperstimulated rats, and this effect is prevented by receptor blockade.
    Gómez R, Simón C, Remohí J, Pellicer A.
    Endocrinology; 2002 Nov 30; 143(11):4339-48. PubMed ID: 12399430
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.